Alercell Inc.

Alercell is a pioneering force in preventative oncology, dedicated to transforming cancer detection and intervention through cutting-edge technology. With a mission to “stop it before it starts,” Alercell integrates AI-driven diagnostics with genetics-based testing to revolutionize early cancer and leukemia detection. In 2024, the company took a major leap forward by incorporating artificial intelligence into molecular diagnostics, reinforcing its commitment to improving patient outcomes through early intervention.  By leveraging advanced AI, precision medicine, and molecular insights, Alercell is redefining the future of oncology diagnostics, ensuring that patients receive the best possible chances for successful treatment—right from the start.